Business Context and Reporting Period
Company: Assembly Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 20, 2018
Context: The filing serves as a Regulation FD disclosure to furnish a corporate presentation intended for use in investor meetings beginning on June 20, 2018. The presentation is available on the company's investor relations website.
Key Financial Metrics
This Form 8-K does not contain specific financial data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The document solely references the existence of an attached corporate presentation (Exhibit 99.1) which contains the relevant business updates.
Material Changes
No material changes to financial results or operations are detailed within the text of this filing. The primary event is the distribution of a corporate presentation to investors.
Guidance, Outlook, and Risks
Management Commentary: The company intends to use the attached presentation in meetings with investors and others.
Legal Status of Information: The information in Item 7.01 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section nor incorporated by reference in other filings, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Corporate Presentation dated June 20, 2018) for specific business updates and financial outlooks not included in this summary.
- Verify the presentation content on the company's official investor website at https://investor.assemblybio.com/events-presentations.
- Note that the presentation is not legally "filed" with the SEC and carries different liability standards than formal financial reports.